Tramadol Tablet is a premium Finished Dosage Form (FDF) and centrally acting synthetic analgesic manufactured by Parand Darou Co. Tramadol features a dual mechanism of action, functioning as a μ-opioid receptor agonist as well as a weak inhibitor of the reuptake of norepinephrine and serotonin. It plays a pivotal role in therapeutic protocols for moderate to severe chronic pain management, providing balanced and sustained analgesic efficacy.
Therapeutic Dosage, Appearance & Packaging
Tramadol tablets are formulated at a therapeutic strength of 200 mg as Round-Flat tablets. To ensure physical stability, product integrity, and standard shelf-life protection, the product is packaged in blister packs containing 3 blisters of 10 tablets (ALU-PVC) per carton.
Regulatory Classification & Dispensing Requirements
Classified strictly as an under control medicine, Tramadol is distributed exclusively upon the presentation of a validated prescription from a certified medical specialist, strictly adhering to regulatory guidelines established by the Food and Drug Administration.
General Information
| Generic Name | Tramadol Tablet | |
| Brand Name | – | |
| Manufacturer | Parand Darou Co. |
Specification
| Dosage Form | Tablet | |
| Strength | 200 mg | |
| Appearance | Round-Flat | |
| Packaging | Each box contains 3 blisters (ALU-PVC) of 10’s | |
| OTC/Prescription/Supplement | Prescription | |
| Route of Administration | ORAL | |
| Access Level | Under control medicine | |
| Category | Opioid Agonist (Moderate to severe chronic pain management) |
